Antileishmanial agent-13 is a quinoline–indigo hybrid compound used as an antileishmanial agent that inhibits Leishmania major strains; it exhibits potent inhibitory activity against both promastigotes and amastigotes with IC50 values of 0.604 μM and 0.508 μM, respectively, through an antifolate mechanism.